Skip to main content
Steven G Deeks

Steven G Deeks

Steven G Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco, and a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. Steven has been engaged in HIV research and clinical care since 1993. He is a recognized expert on HIV-associated immune dysfunction and its impact on HIV persistence (the “reservoir”) and health during antiretroviral therapy. He has published over 600 peer-review articles, editorials and invited reviews on these and related topics.

Steven has been the recipient of several NIH grants and is the contact principal investigator of the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV. He is also the principal investigator of the amfAR Institute for HIV Cure Research.

Steven is the Co-Chair of the Towards an HIV Cure International Working Group and a former Co-Chair of the NIH Office of AIDS Research Toward a Cure Planning Group. He was elected to the American Society for Clinical Investigation and Association of American Physicians, is the Editor-in-Chief of Current Opinion in HIV and AIDS and serves on the scientific advisory board for Science Translational Medicine and the advisory board for EBioMedicine.

In early 2020, he leveraged his HIV research programme to construct the Long-term Impact of Infection with Novel Coronavirus cohort, which is now supporting dozens of studies addressing the impact of SARS-CoV-2 on health. He is a former member of the Office of AIDS Research Advisory Council and the Department on Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. In addition to his clinical and translational investigation, he maintains a primary care clinic for people living with HIV.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.